Y Intercept (Hong Kong) LTD Citius Pharmaceuticals, Inc. Transaction History

Y Intercept (Hong Kong) LTD

  • $1.58 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.58 - $1.03 $225,892 - $401,153
389,469 New
389,469 $225,000
Q1 2023

May 09, 2023
BUY
$0.78 - $1.42 $8,270 - $15,056
10,603 New
10,603 $12,000
Q2 2022

Aug 08, 2022
BUY
$0.88 - $1.87 $15,260 - $32,429
17,342 New
17,342 $16,000

Others Institutions Holding CTXR

# of Institutions
61
Shares Held
23.7M
Call Options Held
83.1K
Put Options Held
32.1K
View Full List

About Citius Pharmaceuticals, Inc.

CTXR Quotes by TradingView
  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $378M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email